BAP1 and neoplasm: The mechanisms resulting in the distinct outcomes of BAP1 loss on the myeloid and lymphoid cell lineages merit further investigation, and may provide insights into the functions of BAP1 and its ASXL binding partners as tumor suppressors (43–45).